PPARA and fatty liver disease: High hepatic expression of FXR protected against hepatic steatosis and elevated TG through the induction of lipolytic target genes in mice (27, 30), while TGR5 activated PPARA to increase mitochondrial oxidative phosphorylation and energy metabolism, as well as reduce obesity in humans (31).